Tags

Type your tag names separated by a space and hit enter

Gestational diabetes: maternal weight gain in relation to fetal growth, treatment modality, BMI and glycemic control.
J Matern Fetal Neonatal Med. 2012 Nov; 25(11):2458-63.JM

Abstract

OBJECTIVES

We sought to determine the impact of maternal weight gain on fetal growth in gestational diabetes (GDM) in relation to treatment modality, body mass index (BMI) and glycemic control.

STUDY DESIGN

Two thousand four hundred fifty-four GDMs were evaluated. Obesity was defined as BMI >29; good glycemic control ≤ 100 mg/dl; maternal age < and >30 years; parity ± 1; large for gestational age (LGA) >90th percentile and small for gestational age (SGA) <10th percentile.

RESULTS

SGA rates were similar in all groups. Obese/overweight diet-treated women in glycemic control showed a four-fold higher rate of LGA compared to insulin-treated women. A 36-lb weight gain in insulin-treated patients had a six-fold higher risk. In poor glycemic control, LGA rates were higher in all BMI/weight gain categories. Logistic regressions for LGA/SGA revealed that level of glycemia, weight gain, parity, obesity and treatment (for LGA only) were significant.

CONCLUSION

Different thresholds used for different maternal BMI categories in addition to the achievement of glycemic control and pharmacological therapy will enhance pregnancy outcome.

Authors+Show Affiliations

Atlantic Maternal Fetal Medicine, Morristown, NJ 07960, USA. Orli_langer@hotmail.comNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

22185433

Citation

Most, Orli, and Oded Langer. "Gestational Diabetes: Maternal Weight Gain in Relation to Fetal Growth, Treatment Modality, BMI and Glycemic Control." The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, vol. 25, no. 11, 2012, pp. 2458-63.
Most O, Langer O. Gestational diabetes: maternal weight gain in relation to fetal growth, treatment modality, BMI and glycemic control. J Matern Fetal Neonatal Med. 2012;25(11):2458-63.
Most, O., & Langer, O. (2012). Gestational diabetes: maternal weight gain in relation to fetal growth, treatment modality, BMI and glycemic control. The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 25(11), 2458-63. https://doi.org/10.3109/14767058.2011.650250
Most O, Langer O. Gestational Diabetes: Maternal Weight Gain in Relation to Fetal Growth, Treatment Modality, BMI and Glycemic Control. J Matern Fetal Neonatal Med. 2012;25(11):2458-63. PubMed PMID: 22185433.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Gestational diabetes: maternal weight gain in relation to fetal growth, treatment modality, BMI and glycemic control. AU - Most,Orli, AU - Langer,Oded, Y1 - 2012/09/05/ PY - 2011/12/22/entrez PY - 2011/12/22/pubmed PY - 2013/5/1/medline SP - 2458 EP - 63 JF - The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians JO - J. Matern. Fetal. Neonatal. Med. VL - 25 IS - 11 N2 - OBJECTIVES: We sought to determine the impact of maternal weight gain on fetal growth in gestational diabetes (GDM) in relation to treatment modality, body mass index (BMI) and glycemic control. STUDY DESIGN: Two thousand four hundred fifty-four GDMs were evaluated. Obesity was defined as BMI >29; good glycemic control ≤ 100 mg/dl; maternal age < and >30 years; parity ± 1; large for gestational age (LGA) >90th percentile and small for gestational age (SGA) <10th percentile. RESULTS: SGA rates were similar in all groups. Obese/overweight diet-treated women in glycemic control showed a four-fold higher rate of LGA compared to insulin-treated women. A 36-lb weight gain in insulin-treated patients had a six-fold higher risk. In poor glycemic control, LGA rates were higher in all BMI/weight gain categories. Logistic regressions for LGA/SGA revealed that level of glycemia, weight gain, parity, obesity and treatment (for LGA only) were significant. CONCLUSION: Different thresholds used for different maternal BMI categories in addition to the achievement of glycemic control and pharmacological therapy will enhance pregnancy outcome. SN - 1476-4954 UR - https://www.unboundmedicine.com/medline/citation/22185433/Gestational_diabetes:_maternal_weight_gain_in_relation_to_fetal_growth_treatment_modality_BMI_and_glycemic_control_ L2 - http://www.tandfonline.com/doi/full/10.3109/14767058.2011.650250 DB - PRIME DP - Unbound Medicine ER -